1. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial;Russell;Lancet,2017
2. [Paying attention to the natural course of disease for a development of gene therapy of inherited retinal disease];Wang;Chin J Experiment Ophthal,2021
3. Principles of Epidemiology,1992
4. Center for drug evaluation of the national medical Products administration;Guidel Clinic Develop Drugs for Rare Dis,2022
5. Early and late stage gene therapy interventions for inherited retinal degenerations;Botto;Prog Retin Eye Res,2022